drugset / Trial / NCT03136835

Maternal Hyperoxygenation in Congenital Heart Disease

NCT03136835

Phase 1/2 Completed 25 enrolled The Hospital for Sick Children
NaSingle-groupOpen-labelTreatment

Summary

A pilot study investigating the safety and feasibility of chronic maternal hyperoxygenation in the setting of fetal congenital heart disease

Timeline

Start
2018-02-02
Primary completion
2024-03-22
Completion
2024-03-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxygen Other / unclassified 4 unknown Other